TLR4 and neoplasm: In a lymphoma mouse model, it is shown that intratumoral injection of TriMix mRNA, encoding costimulatory molecules CD70, CD40 ligand, and constitutively active toll-like receptor 4 (TLR4), induces systemic tumor-specific T cell responses independent of the co-delivery of tumor antigen (82).